Hepatic stellate cells control liver zonation, size and functions via R-spondin 3.
Options
BORIS DOI
Date of Publication
April 2025
Publication Type
Article
Division/Institute
Contributor
Sugimoto, Atsushi | |
Saito, Yoshinobu | |
Wang, Guanxiong | |
Sun, Qiuyan | |
Yin, Chuan | |
Lee, Ki Hong | |
Geng, Yana | |
Rajbhandari, Presha | |
Hernandez, Celine | |
Steffani, Marcella | |
Qie, Jingran | |
Savage, Thomas | |
Goyal, Dhruv M | |
Ray, Kevin C | |
Neelakantan, Taruna V | |
Yin, Deqi | |
Melms, Johannes | |
Lehrich, Brandon M | |
Yasaka, Tyler M | |
Liu, Silvia | |
Oertel, Michael | |
Lan, Tian | |
Guillot, Adrien | |
Peiseler, Moritz | |
Filliol, Aveline | |
Kanzaki, Hiroaki | |
Fujiwara, Naoto | |
Ravi, Samhita | |
Izar, Benjamin | |
Brosch, Mario | |
Hampe, Jochen | |
Remotti, Helen | |
Argemi, Josepmaria | |
Sun, Zhaoli | |
Kendall, Timothy J | |
Hoshida, Yujin | |
Tacke, Frank | |
Fallowfield, Jonathan A | |
Blockley-Powell, Storm K | |
Haeusler, Rebecca A | |
Steinman, Jonathan B | |
Pajvani, Utpal B | |
Monga, Satdarshan P | |
Bataller, Ramon | |
Arpaia, Nicholas | |
Lee, Youngmin A | |
Stockwell, Brent R | |
Augustin, Hellmut G | |
Schwabe, Robert F |
Subject(s)
Series
Nature
ISSN or ISBN (if monograph)
1476-4687
0028-0836
Publisher
Nature Research
Language
English
Publisher DOI
PubMed ID
40074890
Description
Hepatic stellate cells (HSCs) have a central pathogenetic role in the development of liver fibrosis. However, their fibrosis-independent and homeostatic functions remain poorly understood1-5. Here we demonstrate that genetic depletion of HSCs changes WNT activity and zonation of hepatocytes, leading to marked alterations in liver regeneration, cytochrome P450 metabolism and injury. We identify R-spondin 3 (RSPO3), an HSC-enriched modulator of WNT signalling, as responsible for these hepatocyte-regulatory effects of HSCs. HSC-selective deletion of Rspo3 phenocopies the effects of HSC depletion on hepatocyte gene expression, zonation, liver size, regeneration and cytochrome P450-mediated detoxification, and exacerbates alcohol-associated and metabolic dysfunction-associated steatotic liver disease. RSPO3 expression decreases with HSC activation and is inversely associated with outcomes in patients with alcohol-associated and metabolic dysfunction-associated steatotic liver disease. These protective and hepatocyte-regulating functions of HSCs via RSPO3 resemble the R-spondin-expressing stromal niche in other organs and should be integrated into current therapeutic concepts.
File(s)
| File | File Type | Format | Size | License | Publisher/Copright statement | Content | |
|---|---|---|---|---|---|---|---|
| s41586-025-08677-w.pdf | text | Adobe PDF | 90.4 MB | Attribution (CC BY 4.0) | published |